This year has seen a slight decline in digital health funding, but investors are still optimistic about the landscape. In 2024, investors poured millions into startups selling AI-powered healthcare tools, and this is likely to remain true for years to come.
This article offers examples of connections between built environments and health outcomes and regulation of built environments.
This case series discusses the clinical manifestations, management, and outcomes of intoxication from drug-soaked paper strips in a correctional facility population and identifies the specific…
This commentary on a case suggests merits and drawbacks of shared decision-making as one approach to Certificate of Need assessments.
The built environment itself is a kind of medical intervention. Experts examine the role evidence-based design has in improving patient care.
Older adults who are sensitive to the distress of others are more likely to feel anxious or depressed themselves.
Discover innovative insights on family medicine through expert interviews, research highlights, and practical tips in the Annals of Family Medicine Podcast.
With the new year right around the corner, five Advisory Board experts discuss the healthcare topics they’re most looking forward to diving into in 2025…
Editor’s Note: Listen to EP Lab Digest’s podcast discussion with Dr. Tarakji — link is included at the end of this article!
The FDA’s approval marks the second generic approval referencing a GLP-1 receptor agonist in as many months for the agency.
PhRMA’s dues declined after the big drugmakers AbbVie, AstraZeneca, and Teva left the group.
